Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers
- CohBar, Inc. (NASDAQ:CWBR) shares jumped 161% to $4.05 after the company and Morphogenesis announced they have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline.
- HeartCore Enterprises, Inc. (NASDAQ:HTCR) gained 76.6% to $2.26 following better-than-expected first-quarter results.
- Ocean Biomedical, Inc. (NASDAQ:OCEA) shares climbed 63% to $8.57 after the company announced a patent award for novel cancer immunotherapy treatment, granted for prostate cancer, colon cancer, ovarian cancer, kidney cancer, breast cancer, glioblastoma, melanoma and lung cancer.
- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) surged 44% to $1.50 after it was granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation.
- Unique Fabricating, Inc. (NYSE:UFAB) climbed 32.8% to $0.2599 after the company announced an accommodation agreement and new forbearance agreement to support a restructuring or sale.
- Icosavax, Inc. (NASDAQ:ICVX) gained 29.7% to $10.21 after the company announced topline interim Phase 1 results for its bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults.
- mCloud Technologies Corp. (NASDAQ:MCLD) jumped 27% to $0.4567 after the company announced it has formed a special committee for the purpose of exploring strategic alternatives.
- Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) gained 22.6% to $9.96.
- IMAC Holdings, Inc. (NASDAQ:BACK) climbed 21.9% to $0.1702. Theralink signed definitive merger agreement to be acquired by IMAC Holdings.
- TuSimple Holdings Inc. (NASDAQ:TSP) climbed 21.2% to $2.01.
- Lexaria Bioscience Corp. (NASDAQ:LEXX) climbed 20.4% to $0.83. Lexaria Bioscience recently announced it completed its HOR-A22-1 study that showed significant enhancement in the oral delivery of the estrogen hormone estradiol.
- PacWest Bancorp (NASDAQ:PACW) shares gained 20% to $8.23. PacWest Bancorp shares jumped around 20% on Monday after the company announced it entered into a loan purchase and sale agreement with a subsidiary of Kennedy-Wilson Holdings to sell a portfolio of 74 real estate construction loans. DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8.
- Lifecore Biomedical, Inc. (NASDAQ:LFCR) shares gained 18% to $6.32 after the company announced it entered into $150 million in new financing, repaid its outstanding term loans and signed a new supply agreement to expact its HA fermentation capacity with Alcon.
- Quanterix Corporation (NASDAQ:QTRX) gained 17.5% to $22.59. Goldman Sachs upgraded Quanterix from Neutral to Buy and raised the price target from $13 to $27.
- Applied UV, Inc. (NASDAQ:AUVI) shares climbed 15.6% to $0.5512 after posting better-than-expected quarterly sales.
- Angion Biomedica Corp. (NASDAQ:ANGN) gained 15.1% to $0.9159.
- SeqLL Inc. (NASDAQ:SQL) shares surged 15% to $0.46 after gaining over 19% on Monday. SeqLL recently posted a wider first-quarter loss.
- Navigator Holdings Ltd. (NYSE:NVGS) rose 14.2% to $15.00 following strong quarterly sales.
- Myriad Genetics, Inc. (NASDAQ:MYGN) gained 12.9% to $22.67. Goldman Sachs upgraded Myriad Genetics from Sell to Buy and raised the price target from $18 to $25.
- Sarcos Technology and Robotics Corporation (NASDAQ:STRC) surged 11.7% to $0.3857.
- Wallbox N.V. (NYSE:WBX) surged 11.2% to $3.9583.
- Terns Pharmaceuticals, Inc. (NASDAQ:TERN) jumped 11.2% to $12.55.
- AbCellera Biologics Inc. (NASDAQ:ABCL) gained 11% to $7.34.
- Movella Holdings Inc. (NASDAQ:MVLA) rose 9.9% to $2.11 after jumping around 18% on Monday.
- CureVac N.V. (NASDAQ:CVAC) surged 9.5% to $10.59.
- Yelp Inc. (NYSE:YELP) gained 9.2% to $35.51. Activist investor TCS Capital Management has built a stake in Yelp and urged the service-recommendation site to explore strategic alternatives, including a sale, the Wall Street Journal reported.
- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shares rose 5.8% to $1.84. The FDA recently approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants.
Losers
- Netcapital Inc. (NASDAQ:NCPL) shares fell 32.8% to $1.62 after the company reported a registered direct offering of 1.1 million shares at $1.55 per share.
- T2 Biosystems, Inc. (NASDAQ:TTOO) dropped 29% to $0.2001 after the company posted downbeat quarterly results and announced exploration of strategic alternatives and implementation of a restructuring program, including 30% incremental reduction of workforce completed this past week.
- Kaspien Holdings Inc. (NASDAQ:KSPN) fell 27.6% to $0.4427. Kaspien Holdings reported voluntary delisting from the Nasdaq Capital Market effective on or about June 12.
- Evolve Transition Infrastructure LP (NYSE:SNMP) dipped 26.6% to $0.0901 after the company announced a 1-for-30 reverse split.
- Microvast Holdings, Inc. (NASDAQ:MVST) fell 22.3% to $1.71 after the US Energy Department reportedly cancelled contract negotiations for a $200 million award for the company.
- Microbot Medical Inc. (NASDAQ:MBOT) fell 22.1% to $2.4850. Microbot Medical announced a $1.44 million registered direct offering of 655,569 shares of common stock at a price of $2.20 per share priced at the market under Nasdaq rules.
- NantHealth, Inc. (NASDAQ:NH) fell 20.6% to $2.04.
- Oncorus, Inc. (NASDAQ:ONCR) dropped 20% to $0.2480 after the company reported Q1 financial results.
- Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) dropped 20% to $2.96.
- D-Wave Quantum Inc. (NYSE:QBTS) fell 16.7% to $0.8501 after surging 110% on Monday.
- Tenon Medical, Inc. (NASDAQ:TNON) declined 16.1% to $1.36. Tenon Medical recently posted downbeat quarterly results.
- NexImmune, Inc. (NASDAQ:NEXI) dropped 15.2% to $0.4018.
- Achieve Life Sciences, Inc. (NASDAQ:ACHV) declined 14.7% to $6.95 as the company reported topline results from Phase 3 ORCA-3 trial of cytisinicline.
- Integra LifeSciences Holdings Corporation (NASDAQ:IART) fell 13.5% to $43.87 after the company announced it initiated a voluntary global recall of all products manufactured in its Boston facility distributed between March 1, 2018 and May 22, 2023.
- Voyager Therapeutics, Inc. (NASDAQ:VYGR) fell 10.6% to $12.37.
- Kingsoft Cloud Holdings Limited (NASDAQ:KC) dropped 10% to $4.2750 following weak quarterly results.
- Biocept, Inc (NASDAQ:BIOC) shares dropped 9.6% to $4.4491 dipping over 25% on Monday. Biocept recently announced a 1-for-30 reverse stock split.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 9.1% to $0.9277 after reporting results for its first quarter.
- Peraso Inc. (NASDAQ:PRSO) fell 8.3% to $0.3650 after gaining over 53% on Monday.
- Zoom Video Communications, Inc. (NASDAQ:ZM) dropped 7% to $66.42. Zoom Video reported better-than-expected results for its first quarter and raised its full-year sales outlook.
- BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) dropped 6.4% to $65.18 following weak quarterly sales.
Now Read This: Dow Drops Over 100 Points; Lowe's Earnings Top Views